Notch signaling-modified mesenchymal stem cells improve tissue perfusion by induction of arteriogenesis in a rat hindlimb ischemia model
Abstract Notch signaling-modified human mesenchymal stem cell, SB623 cell, is a promising cell therapy product for ischemic stroke. With the aim to expand indications for their use for critical limb-threatening ischemia (CLTI), we hypothesized that SB623 cells improved tissue perfusion by inducing a...
Guardado en:
Autores principales: | Shusaku Maeda, Shigeru Miyagawa, Takuji Kawamura, Takashi Shibuya, Kenichi Watanabe, Takaya Nakagawa, Akima Harada, Dai Chida, Yoshiki Sawa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d4292c66fd8248e985ea76f5ffbfea56 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blood vessel control of macrophage maturation promotes arteriogenesis in ischemia
por: Kashyap Krishnasamy, et al.
Publicado: (2017) -
Combined administration of laminin-221 and prostacyclin agonist enhances endogenous cardiac repair in an acute infarct rat heart
por: Nagako Sougawa, et al.
Publicado: (2021) -
Protease nexin-1 deficiency increases mouse hindlimb neovascularisation following ischemia and accelerates femoral artery perfusion
por: Sonia Selbonne, et al.
Publicado: (2021) -
Development of a drug screening system using three-dimensional cardiac tissues containing multiple cell types
por: Maki Takeda, et al.
Publicado: (2021) -
Low Intrinsic Aerobic Capacity Limits Recovery Response to Hindlimb Ischemia
por: Elizabeth Granier, et al.
Publicado: (2021)